EZH2/EHMT2 Histone Methyltransferases Inhibit the Transcription of DLX5 and Promote the Transformation of Myelodysplastic Syndrome to Acute Myeloid Leukemia
Myelodysplastic syndrome (MDS) is characterized by clonal hematopoiesis and impaired differentiation, and may develop to acute myeloid leukemia (AML). We explored the mechanism of histone methyltransferase EZH2/EHMT2 during the transformation of MDS into AML. Expression of EZH2/EHMT2 in patients and...
Main Authors: | Zhuanzhen Zheng, Ling Li, Guoxia Li, Yaofang Zhang, Chunxia Dong, Fanggang Ren, Wenliang Chen, Yanping Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcell.2021.619795/full |
Similar Items
-
EZH2: a novel target for cancer treatment
by: Ran Duan, et al.
Published: (2020-07-01) -
Altered expression of epigenetic modifiers EZH2, H3K27me3, and DNA methyltransferases in meningiomas – prognostic biomarkers for routine practice
by: Swagatika Samal, et al.
Published: (2020-06-01) -
EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancer
by: Si Sun, et al.
Published: (2020-05-01) -
The Role of the Histone Methyltransferase EZH2 in Liver Inflammation and Fibrosis in STAM NASH Mice
by: Seul Lee, et al.
Published: (2020-05-01) -
Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas
by: Franziska Lea Schümann, et al.
Published: (2021-12-01)